Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2017; 38(02): 228-231
DOI: 10.4103/ijmpo.ijmpo_156_16
Case Report

Metastatic Primary Angiosarcoma of the Breast: Can We Tame It the Metronomic Way

Raja Pramanik
Department of Medical Oncology, BRA-IRCH, AllInstitute of Medical Sciences, New Delhi, India
,
Ajay Gogia
Department of Medical Oncology, BRA-IRCH, AllInstitute of Medical Sciences, New Delhi, India
,
Prabhat Singh Malik
Department of Medical Oncology, BRA-IRCH, AllInstitute of Medical Sciences, New Delhi, India
,
Ramana Gogi
Department of Medical Oncology, BRA-IRCH, AllInstitute of Medical Sciences, New Delhi, India
› Author Affiliations Financial support and sponsorship Nil.
› Further Information
  PDF Download Permissions and Reprints

Abstract

Primary angiosarcoma of the breast is a highly aggressive but rare malignant neoplasm. Palliative chemotherapy with different agents and combinations has been tried in the metastatic setting with poor results. We present the case of a young woman with this disease describing her aggressive course. We used a metronomic combination of oral drugs due to her poor general condition and achieved disease stabilization although not durable.

Keywords

Angiosarcoma - metronomic - propranolol


Publication History

Article published online:
06 July 2021

© 2017. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Raina V, Sengar M, Shukla NK, Deo SS, Mohanty BK, Sharma D, et al. Complete response from thalidomide in angiosarcoma after treatment of breast cancer. J Clin Oncol 2007;25:900-1.
  • 2 Banavali S, Pasquier E, Andre N. Targeted therapy with propranolol and metronomic chemotherapy combination: Sustained complete response of a relapsing metastatic angiosarcoma. Ecancermedicalscience 2015;9:499.
  • 3 Armah HB, Rao UN, Parwani AV. Primary angiosarcoma of the testis: Report of a rare entity and review of the literature. Diagn Pathol 2007;2:23.
  • 4 Babarovic E, Zamolo G, Mustac E, Strcic M. High grade angiosarcoma arising in fibroadenoma. Diagn Pathol 2011;6:125.
  • 5 Borrman R. Metastasis in histologic benign tumors: Case of metastasizing angioma. Beitr Pathol Anat 1907;40:372-93.
  • 6 Johnson CM, Garguilo GA. Angiosarcoma of the breast: A case report and literature review. Curr Surg 2002;59:490-4.
  • 7 Georgiannos SN, Sheaff M. Angiosarcoma of the breast: A 30 year perspective with an optimistic outlook. Br J Plast Surg 2003;56:129-34.
  • 8 Donnell RM, Rosen PP, Lieberman PH, Kaufman RJ, Kay S, Braun DW Jr., et al. Angiosarcoma and other vascular tumors of the breast. Am J Surg Pathol 1981;5:629-42.
  • 9 Bennani A, Chbani L, Lamchahab M, Wahbi M, Alaoui FF, Badioui I, et al. Primary angiosarcoma of the breast: A case report. Diagn Pathol 2013;8:66.
  • 10 Kaklamanos IG, Birbas K, Syrigos KN, Vlachodimitropoulos D, Goutas N, Bonatsos G. Breast angiosarcoma that is not related to radiation exposure: A comprehensive review of the literature. Surg Today 2011;41:163-8.
  • 11 Rosen PP, Kimmel M, Ernsberger D. Mammary angiosarcoma. The prognostic significance of tumor differentiation. Cancer 1988;62:2145-51.
  • 12 Sher T, Hennessy BT, Valero V, Broglio K, Woodward WA, Trent J, et al. Primary angiosarcomas of the breast. Cancer 2007;110:173-8.
  • 13 Mano MS, Fraser G, Kerr J, Gray M, Evans V, Kazmi A, et al. Radiation-induced angiosarcoma of the breast shows major response to docetaxel after failure of anthracycline-based chemotherapy. Breast 2006;15:117-8.
  • 14 Sumikawa Y, Inui S, Nishimura Y, Morita E, Kurachi K. Long-term metronomic docetaxel chemotherapy for inoperative angiosarcoma of the scalp. J Dermatol 2011;38:393-5.
  • 15 Kopp HG, Kanz L, Hartmann JT. Complete remission of relapsing high-grade angiosarcoma with single-agent metronomic trofosfamide. Anticancer Drugs 2006;17:997-8.
  • 16 Vogt T, Hafner C, Bross K, Bataille F, Jauch KW, Berand A, et al. Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors. Cancer 2003;98:2251-6.
  • 17 Mir O, Domont J, Cioffi A, Bonvalot S, Boulet B, Le Pechoux C, et al. Feasibility of metronomic oral cyclophosphamide plus prednisolone in elderly patients with inoperable or metastatic soft tissue sarcoma. Eur J Cancer 2011;47:515-9.
  • 18 Tang J, Li Z, Lu L, Cho CH. β-Adrenergic system, a backstage manipulator regulating tumour progression and drug target in cancer therapy. Semin Cancer Biol 2013;23(6 Pt B):533-42.
  • 19 Stiles JM, Amaya C, Rains S, Diaz D, Pham R, Battiste J, et al. Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma. PLoS One 2013;8:e60021.
  • 20 Chisholm KM, Chang KW, Truong MT, Kwok S, West RB, Heerema-McKenney AE. β-Adrenergic receptor expression in vascular tumors. Mod Pathol 2012;25:1446-51.
  • 21 Pasquier E, Street J, Pouchy C, Carre M, Gifford AJ, Murray J, et al. β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma. Br J Cancer 2013;108:2485-94.
  • 22 Pasquier E, Ciccolini J, Carre M, Giacometti S, Fanciullino R, Pouchy C, et al. Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: Implication in breast cancer treatment. Oncotarget 2011;2:797-809.